How the concept of WHO-listed authorities will change international procurement policies for medicines
Bibliographic Data
| ID | 21879564 |
|---|---|
| Authors | Cécile Macé (Centre d'Investigation Clinique de Nantes), Lembit Rägo (0000-0003-1696-8932, Secretary-General, Council for International Organisations of Medical Sciences, Geneva, Switzerland), Raffaella Ravinetto (0000-0001-7765-2443, Instituut voor Tropische Geneeskunde, corresponding author) |
| Year | 2022 |
| Volume | 6 |
| Issue | Suppl 3 |
| Pages | e008109 |
| Publication date | 2022-02-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMJ Global Health (JOURNAL) |
| Journal identifiers | ISSN: 2059-7908 • E-ISSN: 2059-7908 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/bmjgh-2021-008109 |
| PMID | 35144982 |
| OpenAlex | W4211013955 |
| Language | EN |
| Citations received | 5 |
| References cited | 7 |
Business · Political science · Procurement · Intellectual Property and Patents · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Public Administration · Marketing
Borrowing regulatory capacity in middle-income countries during public health crises
Uncertainties about the quality of medical products globally
Shaping the future of global access to safe, effective, appropriate and quality health products
Strengthening regulatory systems globally
Expanding global vaccine manufacturing capacity
| Citations per year | 1.67 |
|---|---|
| Citation span | 2023 - 2025 (3) |
| Highly cited | No |